Pharminent

Amgen’s cholesterol drug shows positive effect in cardiovascular outcomes study

Amgen’s cholesterol drug Repatha (evolocumab) has showed positive effect in a 27,564-patient cardiovascular outcomes study. http://clinicaltrials.pharmaceutical-business-review.com/news/amgens-cholesterol-drug-shows-positive-effect-in-cardiovascular-outcomes-study-200317-5766473

Filed under: Cardiovascular, PCSK9